The solution for long term surface protection against harmful bacteria and enveloped virus

Bioarmor-nano® are pleased to announce that - in addition to our UK laboratory certification of 99.9% efficacy against Escherichia coli, Staphylococcus aureus and MRSA - Bioarmor-nano® has now been independently laboratory tested to be effective (on non-porous substrates) against phi6 - an enveloped virus with a similar structure to Coronavirus* and Influenza A viruses. The testing was carried out to a modified version of ISO 21702.

In a controlled laboratory environment, a non-porous substrate treated with Bioarmor-nano® demonstrated a reduction of up to 95% of the phi6 enveloped virus after contact with it for 24 hours.

The tests were conducted by an independent UK laboratory using phi6 enveloped virus. Test conditions were based on ISO 21702 on surfaces protected by Bioarmor-nano® products only. 

John Shaw, Bioarmor Europe Director commented: “There is a worldwide shortage of laboratories with the protocols required to test on actual Coronavirus, so as an interim measure we have tested on the phi6 virus. We are currently in the process of negotiating with several high protocol level labs and plan to extend our testing to a mammalian Coronavirus (human or similar) as soon as this becomes possible.”

*SARS-CoV-2 is the virus that causes Covid-19 and is a member of the Coronavirus family of viruses.

Bioarmor-nano® do not make any health claims to persons. Our product claims are based on protection to surfaces against microbes and now viruses. We do not offer protection to the user or others against bacteria or viruses.

Watch our explanation video in animation here: